- Filed
- Apr 2, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 21, 2025 | 183.89M sh |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 24.75M sh |
| Capex | FY 2024 · Dec 31, 2023 | $133K |
| Operating Cash Flow restated | FY 2024 · Dec 31, 2023 | −$8.17M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $0 |
| Current Liabilities restated | FY 2024 · Dec 31, 2023 | $85.48M |
| Total Liabilities restated | FY 2024 · Dec 31, 2023 | $99.93M |
| Current Assets restated | FY 2024 · Dec 31, 2023 | $1.72M |
| Total Assets restated | FY 2024 · Dec 31, 2023 | $5.51M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | −$2.44 |
| Eps Basic | FY 2024 · Dec 31, 2023 | −$2.44 |
| Sga Expense restated | FY 2024 · Dec 31, 2023 | $4.44M |
| Rd Expense | FY 2024 · Dec 31, 2023 | $4.4M |
| Net Income restated | FY 2024 · Dec 31, 2023 | −$60.48M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$8.84M |
| Stockholders Equity restated | FY 2024 · Dec 31, 2022 | −$33.95M |